Could a wearable sensor replace the glucose drink test for diabetes in pregnancy?

NCT ID NCT05430204

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared continuous glucose monitoring (CGM) to the standard glucose challenge test for screening gestational diabetes in over 1,600 pregnant women. The goal was to see if CGM leads to better health outcomes for mothers and babies, such as fewer large babies or birth injuries. Participants wore a CGM device for several days instead of or alongside the usual blood sugar test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

continuous glucose monitor (CGM)

What this could lead to

If successful, CGM could become a better way to screen for gestational diabetes, leading to fewer birth complications and lower healthcare costs.

What could go wrong

This is a completed trial, but results may not apply to all populations or settings. CGM is more complex and costly than standard screening, which could limit widespread use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Texas Health Science Center at Houston

    Houston, Texas, 77030, United States